1. ANXA2 and Rac1 negatively regulates autophagy and osteogenic differentiation in osteosarcoma cells to confer CDDP resistance
   Baolong Pan et al, 2023, Biochemical and Biophysical Research Communications CrossRef
2. Nanoliposomes for doxorubicin delivery: Reversing drug resistance, stimuli-responsive carriers and clinical translation
   Mehrdad Hashemi et al, 2023, Journal of Drug Delivery Science and Technology CrossRef
3. The Targeted Therapies for Osteosarcoma via Six Major Pathways
   Shuxing Wang et al, 2023, Current Molecular Pharmacology CrossRef
4. Blockade of CXCR4 promotes macrophage autophagy through the PI3K/AKT/mTOR pathway to alleviate coronary heart disease
   Fangqin Li et al, 2023, International Journal of Cardiology CrossRef
5. Photothermal-triggered immunogenic nanotherapeutics for optimizing osteosarcoma therapy by synergizing innate and adaptive immunity
   Kaiyuan Liu et al, 2022, Biomaterials CrossRef
6. Autophagy and its role in osteosarcoma
   Biao Ning et al, 2023, Cancer Medicine CrossRef
7. Functional role of MicroRNA/PI3K/AKT axis in osteosarcoma
   Yubo Xiang et al, 2023, Frontiers in Oncology CrossRef
8. New emerging targets in osteosarcoma therapy: PTEN and PI3K/Akt crosstalk in carcinogenesis
   Mehrdokht Sadrkhanloo et al, 2023, Pathology - Research and Practice CrossRef
9. HIF‐1α mediates CXCR4 transcription to activate the AKT/mTOR signaling pathway and augment the viability and migration of activated B cell‐like diffuse large B‐cell lymphoma cells
   Zhen Jin et al, 2023, Molecular Carcinogenesis CrossRef